Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
13 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/13/3080051/37519/en/Akebia-Therapeutics-to-Present-at-the-H-C-Wainwright-3rd-Annual-BioConnect-Investor-Conference.html
08 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/08/3077065/37519/en/Akebia-Therapeutics-Reports-First-Quarter-2025-Financial-Results-and-Recent-Business-Highlights.html
01 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/01/3072856/37519/en/Akebia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
01 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/01/3072305/37519/en/Akebia-Therapeutics-to-Report-First-Quarter-2025-Financial-Results-and-Discuss-Recent-Business-Highlights.html
03 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/03/3055119/37519/en/Akebia-Therapeutics-Announces-Positive-Opinion-of-European-Medicines-Agency-for-XOANACYL-an-Oral-Therapy-for-Chronic-Kidney-Disease-Licensed-to-Averoa.html
02 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/02/3054681/37519/en/Akebia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
ABOUT THIS PAGE